Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the MERLIN project. You can find more details about the Conference here.
- RT @adipoa2: Shout out to our dedicated followers! Our project has recently ended but please check out our follow on @EU_H2020 project @Aut… Time ago 111 Days via Twitter for iPhone
- RT @AutoCRAT2020: #MyFirstTweet! Greetings all! We are a @EU_H2020 research project! Please follow us if you are interested in #celltherapy… Time ago 172 Days via Twitter for iPhone
- RT @FP7Merlin: Up to 56 patients are being recruited to take part in the @FP7Merlin trial, which will investigate the safety and efficacy o… Time ago 182 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.